The scientific program of the DZD is divided into six research areas that are closely linked.
In large population studies, the DZD investigates the effects of the environment, lifestyle and genes on the development of diabetes. In the future, new biomarkers shall improve the diagnosis of diabetes.
Using genetic and cell biology techniques, the DZD is working to elucidate the molecular mechanisms of diabetes. The aim is to identify new biomarkers and to find concepts for drugs.
The preservation or restoration of the activity of the beta cells is crucial to prevent the onset of diabetes.
In clinical trials, new prevention and treatment strategies are being developed for at-risk individuals or patients with diabetes.
The DZD wants to elucidate the mechanisms leading to the development of type 1 diabetes. The objectives are to identify markers that enable early diagnosis as well as the development of therapies for the prevention and cure of diabetes.
The DZD is working to discover, validate and further develop new drug candidates and targets for innovative drugs.